Torray Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$16.4M |
| 2 |
Danaher
DHR
|
+$15.6M |
| 3 |
RTX Corp
RTX
|
+$15.6M |
| 4 |
Qualcomm
QCOM
|
+$15.4M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$5.4M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$2.23M |
| 3 |
General Dynamics
GD
|
+$1.99M |
| 4 |
Wells Fargo
WFC
|
+$1.84M |
| 5 |
Johnson & Johnson
JNJ
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.29% |
| 2 | Healthcare | 15.9% |
| 3 | Industrials | 13.2% |
| 4 | Financials | 13.04% |
| 5 | Energy | 8.62% |
Similar funds
Torray Investment Partners's Q2 2014 Portfolio in Review
As of Q2 2014, Torray Investment Partners held 94 positions worth $987M, up 67% from $590M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Torray Investment Partners deployed $349M of net new capital in Q2 2014, opening 7 new positions and adding to 45 existing holdings. Its largest new stake was DIRECTV COM STK (DE): 120,200 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Du Pont De Nemours E I, an estimated $2.23M trimmed.
- Torray Investment Partners's largest Q2 2014 buy was DIRECTV COM STK (DE): 120,200 shares worth $10.2M.
- Torray Investment Partners added most to Visa in Q2 2014, an estimated $16.4M increase.
- Torray Investment Partners's biggest Q2 2014 reduction was Du Pont De Nemours E I, cutting an estimated $2.23M.
- Torray Investment Partners fully exited Vertex Pharmaceuticals in Q2 2014, selling an estimated $5.4M.
- Torray Investment Partners's ten largest holdings make up 26% of its $987M portfolio in Q2 2014.
- Torray Investment Partners opened 7 new positions and closed 3 in Q2 2014.
- Torray Investment Partners's portfolio value rose 67% quarter-over-quarter to $987M.
Based on Torray Investment Partners's 13F filing for Q2 2014, filed 14 Aug 2014.